JPWO2006129472A1 - Capsule endoscope - Google Patents

Capsule endoscope Download PDF

Info

Publication number
JPWO2006129472A1
JPWO2006129472A1 JP2007518896A JP2007518896A JPWO2006129472A1 JP WO2006129472 A1 JPWO2006129472 A1 JP WO2006129472A1 JP 2007518896 A JP2007518896 A JP 2007518896A JP 2007518896 A JP2007518896 A JP 2007518896A JP WO2006129472 A1 JPWO2006129472 A1 JP WO2006129472A1
Authority
JP
Japan
Prior art keywords
capsule endoscope
capsule
group
surface portion
endoscope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007518896A
Other languages
Japanese (ja)
Other versions
JP5003486B2 (en
Inventor
羽生 武
武 羽生
晴彦 佐久間
晴彦 佐久間
竹山 敏久
敏久 竹山
後藤 成人
成人 後藤
梅木 守
守 梅木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Konica Minolta Medical and Graphic Inc
Original Assignee
Konica Minolta Medical and Graphic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Konica Minolta Medical and Graphic Inc filed Critical Konica Minolta Medical and Graphic Inc
Priority to JP2007518896A priority Critical patent/JP5003486B2/en
Publication of JPWO2006129472A1 publication Critical patent/JPWO2006129472A1/en
Application granted granted Critical
Publication of JP5003486B2 publication Critical patent/JP5003486B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/04Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor combined with photographic or television appliances
    • A61B1/041Capsule endoscopes for imaging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Optics & Photonics (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endoscopes (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

本発明は、対物レンズ、照明光源部、固体撮像素子等が一体に組み込まれた錠剤カプセル形状からなり、体腔内消化器のいずれにおいても消化器内を円滑に進行し、耐久性に優れ、かつ鮮明な画像が得られる医療用のカプセル内視鏡を提供する。本発明の医療用のカプセル内視鏡は、濡れ指数が40mN/m以上の表面部Aを有することを特徴とする。The present invention has a tablet capsule shape in which an objective lens, an illumination light source unit, a solid-state imaging device and the like are integrated, and smoothly progresses in the digestive organ in any body cavity digestive device, and has excellent durability, and Provided is a capsule endoscope for medical use capable of obtaining a clear image. The medical capsule endoscope of the present invention is characterized by having a surface portion A having a wetting index of 40 mN / m or more.

Description

本発明は、カプセル内視鏡に関し、詳しくは、対物レンズ、照明光源部、固体撮像素子等が一体に組み込まれた錠剤カプセル形状からなり、体腔内の消化器のいずれにおいても消化器内を円滑に進行し、鮮明な画像が得られる医療用のカプセル内視鏡に関するものである。   The present invention relates to a capsule endoscope. Specifically, the capsule endoscope has a tablet capsule shape in which an objective lens, an illumination light source unit, a solid-state imaging device, and the like are integrally incorporated, and the digestive organ can be smoothly moved in any digestive organ in a body cavity. In particular, the present invention relates to a medical capsule endoscope that can obtain a clear image.

現在、医療分野で体腔内の診断や治療において、ファイバースコープや電子内視鏡装置が広く用いられている。これらの装置は、先端に撮像素子等を備えた管状の挿入部と、この挿入部に連設される操作部、およびこれに接続される画像処理装置並びに表示装置等を有し、挿入部を被検者の体腔内へと挿入し、撮像することにより体腔内における所望の部位を観察、検査し得る内視鏡装置である。このような内視鏡装置は、体腔内に挿入される挿入部の太さや長さ、複雑な形状等から練習に練習を重ね熟練した医師や技術者が装置を操作し、観察や検査等を行う必要があった。また、これらの内視鏡装置は、体腔内への挿入時に、被験者の苦痛を伴うものであった。   Currently, fiberscopes and electronic endoscope devices are widely used in the medical field for diagnosis and treatment in body cavities. These devices have a tubular insertion portion having an image pickup device or the like at the tip, an operation portion connected to the insertion portion, an image processing device connected to the insertion portion, a display device, and the like. An endoscope apparatus that can be inserted into a body cavity of a subject and imaged to observe and inspect a desired site in the body cavity. Such an endoscopic device is practiced by practicing from the thickness and length of the insertion part inserted into the body cavity, complicated shape, etc., and a skilled doctor or engineer operates the device to perform observation, inspection, etc. There was a need to do. In addition, these endoscope apparatuses are accompanied by pain of the subject when inserted into the body cavity.

上記のような課題に対し、近年、錠剤カプセル形状の筐体の内部に撮影光学系を有する固体撮像素子等を収納した超小型の内視鏡、いわゆるカプセル内視鏡が開発されている。このカプセル内視鏡は、これを被検者が嚥下する等によって体腔内へと容易に挿入され、患部等を撮像し、その画像データを体内から発信し、体外で受信する無線通信手段によって、小腸等の臓器の観察や検査等をも容易にした(例えば、特許文献1参照。)。
特開平7−289504号公報
In response to the above problems, in recent years, a so-called capsule endoscope has been developed in which a solid-state image pickup device having a photographing optical system and the like is housed in a tablet capsule-shaped housing. This capsule endoscope is easily inserted into a body cavity by, for example, the subject swallowing it, images the affected area, transmits the image data from the body, and receives it outside the body, Observation and inspection of organs such as the small intestine were also facilitated (see, for example, Patent Document 1).
JP 7-289504 A

しかしながら、体腔内部を円滑に撮影するには、消化液が分泌されている消化管の内部表面に適した設計が必要とされるが、単に親水性がよいという特性のみに着眼した発想に留まっているのが現状である。カプセル内視鏡の表面部材が親水性という表面状態にあっても、胃部を通過するときには、pH1〜2の強酸性下であり、小腸や大腸では逆に中性または弱アルカリ性である。また、消化器官により、消化液や分泌物がレンズ表面や照明器具の表面を被覆し、透過率の低下や発光量の低下を引き起こし、撮像画像を不鮮明にする。また、消化液や分泌物の粘着性や消化器の内面の凹凸度の程度により、消化器内を円滑に進行しないため、撮像画像の鮮明性低下を招いているのが現状である。   However, in order to capture the inside of the body cavity smoothly, a design suitable for the inner surface of the digestive tract where the digestive juice is secreted is required, but the idea is focused solely on the property of good hydrophilicity. The current situation is. Even when the surface member of the capsule endoscope is in a hydrophilic state, when it passes through the stomach, it is under strong acidity of pH 1-2, and in contrast, it is neutral or weakly alkaline in the small intestine and large intestine. In addition, the digestive organs and secretions cover the lens surface and the surface of the luminaire by the digestive organs, causing a decrease in transmittance and a decrease in the amount of luminescence, thereby blurring the captured image. In addition, due to the adhesiveness of digestive juices and secretions and the degree of unevenness of the inner surface of the digestive organ, the digestive organ does not proceed smoothly, resulting in a decrease in the sharpness of the captured image.

本発明は、上記課題に鑑みなされたものであり、その目的は、対物レンズ、照明光源部、固体撮像素子等が一体に組み込まれた錠剤カプセル形状からなり、体腔内消化器のいずれにおいても消化器内を円滑に進行し、耐久性に優れ、かつ鮮明な画像が得られる医療用のカプセル内視鏡を提供することにある。   The present invention has been made in view of the above-mentioned problems, and its purpose is a tablet capsule shape in which an objective lens, an illumination light source unit, a solid-state imaging device, and the like are integrally incorporated, and digestion is performed in any of the body cavity digestive organs. It is an object of the present invention to provide a medical capsule endoscope that can smoothly travel in a vessel, has excellent durability, and provides a clear image.

本発明の上記課題は以下の構成により達成される。   The above object of the present invention is achieved by the following configurations.

1.濡れ指数が40mN/m以上の表面部Aを有することを特徴とするカプセル内視鏡。   1. A capsule endoscope having a surface portion A having a wetting index of 40 mN / m or more.

2.前記表面部Aが、レンズ及び照明体を収納した撮影部の保護部材であることを特徴とする前記1に記載のカプセル内視鏡。   2. 2. The capsule endoscope according to 1 above, wherein the surface portion A is a protective member of an imaging unit that houses a lens and an illuminating body.

3.前記表面部Aが、レンズ表面または照明体表面であることを特徴とする前記1に記載のカプセル内視鏡。   3. 2. The capsule endoscope according to 1, wherein the surface portion A is a lens surface or an illuminator surface.

4.前記表面部Aが、コロナ放電処理またはプラズマ放電処理されていることを特徴とする前記1〜3のいずれか1項に記載のカプセル内視鏡。   4). 4. The capsule endoscope according to any one of claims 1 to 3, wherein the surface portion A is subjected to corona discharge treatment or plasma discharge treatment.

5.前記表面部Aを構成する素材が、ノニオン性基またはアニオン性基を有するポリマーであることを特徴とする前記1〜4のいずれか1項に記載のカプセル内視鏡。   5. 5. The capsule endoscope according to any one of claims 1 to 4, wherein the material constituting the surface portion A is a polymer having a nonionic group or an anionic group.

6.前記ノニオン性基が、単独の水酸基、複数の水酸基を有する糖鎖構造及びアルキレンオキサイド基から選ばれる少なくとも1つであることを特徴とする前記5に記載のカプセル内視鏡。   6). 6. The capsule endoscope according to 5, wherein the nonionic group is at least one selected from a single hydroxyl group, a sugar chain structure having a plurality of hydroxyl groups, and an alkylene oxide group.

7.前記アニオン性基が、スルホン酸基または燐酸基であることを特徴とする前記5に記載のカプセル内視鏡。   7. 6. The capsule endoscope according to 5, wherein the anionic group is a sulfonic acid group or a phosphoric acid group.

本発明によれば、対物レンズ、照明光源部、固体撮像素子等が一体に組み込まれた錠剤カプセル形状からなり、体腔内消化器のいずれにおいても消化器内を円滑に進行し、耐久性に優れ、かつ鮮明な画像が得られる医療用のカプセル内視鏡を提供することができる。   According to the present invention, it has a tablet capsule shape in which an objective lens, an illumination light source unit, a solid-state imaging device and the like are integrally incorporated, and smoothly progresses in the digestive organ in any body cavity digestive device, and has excellent durability. In addition, it is possible to provide a medical capsule endoscope that can obtain a clear image.

本発明のカプセル内視鏡の実施形態の一例を示す全体概略図である。It is a whole schematic diagram showing an example of an embodiment of a capsule endoscope of the present invention. 本発明のカプセル内視鏡の実施形態の他の一例を示す全体概略図である。It is the whole schematic figure which shows another example of embodiment of the capsule endoscope of this invention.

符号の説明Explanation of symbols

1 カプセル内視鏡のポリマー筐体
2 対物レンズ
3 撮像素子
4 発光モジュール
5 光源部
6 送信手段
7 受信手段
8 アンテナ
9 蓄電手段
10 薬剤保持手段
S 撮影部の保護部材
a カプセル内視鏡の長軸長
b カプセル内視鏡の短軸長
DESCRIPTION OF SYMBOLS 1 Capsule endoscope polymer housing 2 Objective lens 3 Imaging element 4 Light emitting module 5 Light source unit 6 Transmitting unit 7 Receiving unit 8 Antenna 9 Power storage unit 10 Drug holding unit S Protective member of imaging unit a Long axis of capsule endoscope Length b Short axis length of capsule endoscope

以下、本発明を実施するための最良の形態について詳細に説明する。   Hereinafter, the best mode for carrying out the present invention will be described in detail.

本発明者は、上記課題に鑑み鋭意検討を行った結果、対物レンズ、照明光源部、固体撮像素子等が一体に組み込まれた錠剤カプセル形状からなり、濡れ指数が40mN/m以上の表面部Aを有することを特徴とするカプセル内視鏡により、体腔内消化器のいずれにおいても消化器内を円滑に進行し、鮮明な画像が得られる医療用のカプセル内視鏡を実現できることを見出し、本発明に至った次第である。   As a result of intensive studies in view of the above problems, the present inventor has a tablet capsule shape in which an objective lens, an illumination light source unit, a solid-state imaging device, and the like are integrally incorporated, and a surface portion A having a wetting index of 40 mN / m or more. It has been found that a capsule endoscope for medical use that can smoothly progress through the digestive organ and obtain a clear image in any of the digestive organs in the body cavity can be realized by using a capsule endoscope characterized by having It is up to the invention.

はじめに、本発明のカプセル内視鏡の全体形態を説明する。   First, the whole form of the capsule endoscope of the present invention will be described.

図1は、本発明のカプセル内視鏡の実施形態の一例を示す全体概略図である。   FIG. 1 is an overall schematic view showing an example of an embodiment of a capsule endoscope of the present invention.

図1に示すように、本発明のカプセル内視鏡1は、いわゆる画像を無線送受信可能な操作手段と分離して独立に移動する超小型内視鏡であり、撮影画像の無線送受信可能な電子内視鏡であり、観察機能手段は対物レンズ2と撮像素子3で観察光学系が構成され、この撮像素子3は1画素が0.1μm〜3μmの間隔に並ぶ微細CCDまたはCMOSが採用される。また、照明光学系を構成する発光モジュール4及び光源部5は、白色、緑色、赤色のLED(以下、LEDともいう)が常用される。これらの観察光学系及び照明光学系の外部には、保護部材Sが設けられている。本発明のカプセル内視鏡においては、この保護部材Sの表面を、濡れ指数が40mN/m以上の表面部Aとすることが好ましい。   As shown in FIG. 1, a capsule endoscope 1 according to the present invention is an ultra-small endoscope that moves independently from an operation means capable of wirelessly transmitting and receiving a so-called image. It is an endoscope, and an observation optical system is composed of an objective lens 2 and an image sensor 3 as an observation function means, and this image sensor 3 employs a fine CCD or CMOS in which one pixel is arranged at intervals of 0.1 μm to 3 μm. . Moreover, as the light emitting module 4 and the light source unit 5 constituting the illumination optical system, white, green, and red LEDs (hereinafter also referred to as LEDs) are commonly used. A protective member S is provided outside these observation optical system and illumination optical system. In the capsule endoscope of the present invention, the surface of the protective member S is preferably a surface portion A having a wetting index of 40 mN / m or more.

無線の送受信用のアンテナ8は、照明光学系の反対側に送信手段6、受信手段7、蓄電手段10とともに配置される。空間部分9には、患部に送る薬液の格納室であり、場合によっては、患部の生検体試料を採取後格納する試料室ともなる。10の蓄電手段は、外部から送信される超音波や磁界、電界により、照明用のLEDを発光させる電源に変換する変電器であっても良い。   The wireless transmission / reception antenna 8 is disposed on the opposite side of the illumination optical system together with the transmission means 6, the reception means 7, and the power storage means 10. The space portion 9 is a storage chamber for the chemical solution to be sent to the affected area, and in some cases, it is also a sample chamber for storing the living specimen sample of the affected area. The power storage means 10 may be a transformer that converts the illumination LED into a power source that emits light using an ultrasonic wave, a magnetic field, or an electric field transmitted from the outside.

本発明のカプセル内視鏡の必要とする系は、上述の様に少なくとも観察光学系、照明光学系、アンテナ系、送受信機系であり、その他にエネルギーを供給する蓄電系、DDS系、生検査用試料採取系等である。   The system required for the capsule endoscope of the present invention is at least the observation optical system, the illumination optical system, the antenna system, and the transceiver system as described above. In addition, a power storage system that supplies energy, a DDS system, and a live inspection Sample collection system.

カプセル内視鏡は、上部消化器及び下部消化器内を速やかに移動できるように概略鶏卵形を小さくしたものであって、上面、側面から概略楕円形が好ましいが、球形、ラクビーボール型のようであっても良い。球形の場合、球形に近いほど姿勢制御は行いづらく、一定の方向の撮影に工夫が必要になる。本発明のカプセル内視鏡においては、例えば、特開2001−174713号公報に記載のような光学系を採用することにより、所望の部位の撮影が可能になる。即ち、対物光学系によれば、反射面の組み合わせあるいは反射面と屈折面の組み合わせにより、光学系の全長を短くすることができるので、小さな反射スペースで広角な観察が可能な小型の対物光学系が実現する。また、上記対物光学系を本発明の内視鏡に適用することにより、内視鏡の軸方向に直交する周囲方向の全周にわたる観察が可能な小型の内視鏡を得ることができる。   The capsule endoscope has a roughly egg-shaped shape so that it can be quickly moved in the upper and lower digestive organs, and is preferably roughly elliptical from the top and side, but it is like a spherical or rugby ball type. It may be. In the case of a sphere, the closer to the sphere, the harder it is to control the posture, and it is necessary to devise shooting in a certain direction. In the capsule endoscope of the present invention, for example, by adopting an optical system as described in Japanese Patent Application Laid-Open No. 2001-174713, a desired part can be imaged. That is, according to the objective optical system, the total length of the optical system can be shortened by the combination of the reflecting surfaces or the combination of the reflecting surface and the refracting surface. Is realized. Further, by applying the objective optical system to the endoscope of the present invention, it is possible to obtain a small-sized endoscope capable of observation over the entire circumference in the circumferential direction orthogonal to the axial direction of the endoscope.

カプセル内視鏡のアスペクト比として、先ずカプセル内視鏡に外接する円柱を描きその円柱の体積が最小になるように設定したとき、図1に示すように、直径をカプセル内視鏡の短軸長bとし、円柱の長さをカプセル内視鏡の長軸長aとすると、a/b比をアスペクト比と定義する。このアスペクト比が1以上、2.3以下であることが好ましい。特に好ましい範囲は1以上、2以下である。   As the aspect ratio of the capsule endoscope, when a cylinder circumscribing the capsule endoscope is first drawn and the volume of the cylinder is set to a minimum, as shown in FIG. 1, the diameter is set to the short axis of the capsule endoscope. If the length is b and the length of the cylinder is the long axis length a of the capsule endoscope, the a / b ratio is defined as the aspect ratio. The aspect ratio is preferably 1 or more and 2.3 or less. A particularly preferred range is 1 or more and 2 or less.

撮像素子3であるCCD又はCMOSに観察像を結像させるための対物レンズ2は、例えば、非球面対物レンズは単又は複数配置される。これら非球面レンズの採用はレンズ枚数を減らせるのでカプセル部の全長を短くして、嚥下性を向上させることができる。   As the objective lens 2 for forming an observation image on the CCD or CMOS which is the image pickup device 3, for example, an aspherical objective lens is arranged singly or in plural. Adoption of these aspherical lenses can reduce the number of lenses, so that the total length of the capsule portion can be shortened and swallowability can be improved.

本発明のカプセル内視鏡においては、カプセル本体で構成されるカプセルの外表面に潤滑性材料である親水性媒体を塗工又は表面処理される。このことにより、カプセル内視鏡1を嚥下した際、消化器内の分泌物と親水性媒体とが親和して、前記カプセル内視鏡1の消化管腔との間の潤滑性が向上し、消化管を損傷させることなく、速やかに移動することができ、その結果、鮮明な画像を得ることができる。   In the capsule endoscope of the present invention, a hydrophilic medium, which is a lubricating material, is applied or surface-treated on the outer surface of the capsule constituted by the capsule body. By this, when the capsule endoscope 1 is swallowed, the secretions in the digestive tract and the hydrophilic medium are compatible, and the lubricity between the capsule endoscope 1 and the digestive tract cavity is improved. It can move quickly without damaging the digestive tract, and as a result, a clear image can be obtained.

本発明のカプセル内視鏡1は、体腔外に設けた撮像素子3の駆動及び出力される信号の処理及び照明手段4への電力の供給を行う電装手段、液晶表示素子と組み合わせて内視鏡観察系を構成し、前記撮像素子3で撮像した内視鏡画像が体外に設置された液晶モニタ上に鮮明に表示される。   The capsule endoscope 1 according to the present invention is an endoscope that is combined with an electric device that drives an imaging device 3 provided outside the body cavity, processes an output signal, and supplies power to the illumination unit 4, and a liquid crystal display device. The endoscope system which comprises an observation system and was imaged with the said image pick-up element 3 is displayed clearly on the liquid crystal monitor installed outside the body.

カプセル内視鏡による撮影記録は、例えば、小型記憶媒体に記録され画像処理を行い、病変部を抽出し、早期発見が可能になる。電装装置は、病院内電源又は家庭用電源、太陽電池、燃料電池等によって駆動される。   Shooting and recording with a capsule endoscope is recorded on a small storage medium, image processing is performed, and a lesion is extracted to enable early detection. The electrical equipment is driven by a hospital power source or a household power source, a solar cell, a fuel cell, or the like.

図2は、本発明のカプセル内視鏡の実施形態の他の一例を示す全体概略図である。   FIG. 2 is an overall schematic diagram showing another example of the embodiment of the capsule endoscope of the present invention.

基本的は構成は上記の図1と同様であるが、図2では、観察光学系及び照明光学系の外部には保護部材Sを設けず、対物レンズ2及び光源部5で最外部の一部を構成する形態であり、これらの対物レンズ2または光源部5の表面を、濡れ指数が40mN/m以上の表面部Aとすることが好ましい形態の一つである。   Basically, the configuration is the same as in FIG. 1, but in FIG. 2, the protective member S is not provided outside the observation optical system and the illumination optical system, and the objective lens 2 and the light source unit 5 are part of the outermost part. The surface of the objective lens 2 or the light source unit 5 is preferably a surface unit A having a wetting index of 40 mN / m or more.

次いで、本発明に係る濡れ指数が40mN/m以上の表面部Aの詳細について説明する。   Next, details of the surface portion A having a wetting index of 40 mN / m or more according to the present invention will be described.

前述したように胃部消化器は、蛋白質を分解する環境としてpHが1に近い強酸性環境であるが、親水性基としてカルボキシル基を有するポリマーでは、カルボキシル基にプロトンが付与されるため、酸性環境下での親水性が弱い。これに対し、スルホン酸基のようにpH1でもイオン解離する基あるいはイオン解離しなくても親水性基であるアルキレンオキサイド基やヒドロキシ基等の官能基をもつポリマーでは、強酸性環境でも親水性を維持することができ好ましい。ただし、このようなポリマーを使用すると、ポリマー膜を通して内部の撮像電装系に水分や塩分が浸透し、作動不良を起こすことがあり、内視鏡の外殻の最外表面を除く内部は、水不透性のポリマーで構成することが好ましい。   As described above, the gastrointestinal tract is a strongly acidic environment with a pH close to 1 as an environment for degrading proteins. However, in a polymer having a carboxyl group as a hydrophilic group, a proton is imparted to the carboxyl group. Poor hydrophilicity in the environment. In contrast, polymers having functional groups such as alkylene oxide groups and hydroxy groups that are ionic dissociation even at pH 1 or ionic dissociation, such as sulfonic acid groups, have hydrophilicity even in strongly acidic environments. This is preferable because it can be maintained. However, if such a polymer is used, moisture and salt may permeate into the internal imaging electrical system through the polymer film, resulting in malfunction. The interior of the endoscope except for the outermost surface is water. It is preferable to comprise an impermeable polymer.

本発明のカプセル内視鏡においては、濡れ指数が40mN/m以上の表面部を有することを特徴とする。   The capsule endoscope of the present invention is characterized by having a surface portion with a wetting index of 40 mN / m or more.

本発明でいう濡れ指数とは、親水化の程度を評価する試験法であり、表面張力が順を追って異なる様な一連の混合溶媒(例えば、ホルムアミドとエチレングリコールモノエチルエーテル)を、ポリマー部材の表面部に塗布し、ちょうどポリマー部材表面を濡らすと判定された混合溶媒の表面張力の数値(mN/m)を濡れ指数と定義され、「ポリエチレンおよびポリプロピレンフィルムのぬれ試験方法」(JIS K 6768)に定められた方法に従って、市販されている濡れ性標準試薬31mN/m〜54mN/m(数値の大きいほど親水性が向上する)を綿棒に浸し、それを被験体の表面に塗布して測定する。   The wetting index in the present invention is a test method for evaluating the degree of hydrophilization, and a series of mixed solvents (for example, formamide and ethylene glycol monoethyl ether) whose surface tensions are different in order are used for the polymer member. The numerical value of the surface tension (mN / m) of the mixed solvent that was applied to the surface portion and was just determined to wet the surface of the polymer member was defined as the wetting index, and “wetting test method for polyethylene and polypropylene films” (JIS K 6768). In accordance with the method defined in 1., a commercially available wettability standard reagent of 31 mN / m to 54 mN / m (the higher the value, the more hydrophilic is improved) is immersed in a cotton swab and applied to the surface of the subject for measurement. .

本発明に係る濡れ指数が40mN/m以上の表面部を構成するポリマーとしては、特に制限はないが、ノニオン性基またはアニオン性基を有するポリマーであることが好ましい。更に、ノニオン性基としては、単独の水酸基、複数の水酸基を有する糖鎖構造及びアルキレンオキサイド基から選ばれる少なくとも1つであるが好ましく、また、アニオン性基としては、スルホン酸基または燐酸基であることが好ましい。   The polymer constituting the surface portion having a wetting index of 40 mN / m or more according to the present invention is not particularly limited, but is preferably a polymer having a nonionic group or an anionic group. Further, the nonionic group is preferably at least one selected from a single hydroxyl group, a sugar chain structure having a plurality of hydroxyl groups, and an alkylene oxide group, and the anionic group is a sulfonic acid group or a phosphoric acid group. Preferably there is.

このようなポリマーとしては、例えば、メタクリル酸メチル等のアクリル酸アルキルエステル類、エチレン、プロピレン、ブタジエン、イソプレン等の不飽和オレフィンポリマー類、これらの不飽和オレフィンと共重合させたシクロオレフィンポリマー類、ノルボルネン樹脂等のシクロオレフィンポリマーの単独ポリマー、ポリカーボネート類、スチレン、酢酸ビニルポリマー、フェノール樹脂、シリコン樹脂等を挙げることができる。   Examples of such polymers include acrylic acid alkyl esters such as methyl methacrylate, unsaturated olefin polymers such as ethylene, propylene, butadiene, and isoprene, and cycloolefin polymers copolymerized with these unsaturated olefins. Examples thereof include a single polymer of cycloolefin polymer such as norbornene resin, polycarbonates, styrene, vinyl acetate polymer, phenol resin, silicon resin and the like.

本発明に係るポリマーでは、酸素の存在化で処理すると、ポリマー表面の炭化水素基に水酸基に置換された表面を得ることができる。表面に水酸基をもつように改変した後は、アルキレンオキサイド又はその誘導体等を反応させてアルキレンオキサイド基をもつように改質ができる。また、水酸基を利用してスルホン酸基をもつ置換基を導入して親水性化処理をすることができる。これらの表面改質は、表面から1nm〜1000nm程の改質で好ましい結果が得られる。   When the polymer according to the present invention is treated in the presence of oxygen, a surface in which a hydrocarbon group on the polymer surface is substituted with a hydroxyl group can be obtained. After the surface is modified to have a hydroxyl group, it can be modified to have an alkylene oxide group by reacting with alkylene oxide or a derivative thereof. Further, a hydrophilic group can be treated by introducing a substituent having a sulfonic acid group using a hydroxyl group. With these surface modifications, favorable results can be obtained with modifications of about 1 nm to 1000 nm from the surface.

また、本発明に係る上記ポリマーは、いずれも親水性が低いので、表面を親水性化処理を施すことが好ましく、親水性化処理としては、例えば、表面をコロナ放電処理、プラズマ処理、アーク放電処理、火炎処理などがあるが、得られる親水化効果や親水性付与の容易性の観点から、コロナ放電処理やプラズマ処理が好ましい。   In addition, since the polymers according to the present invention have low hydrophilicity, it is preferable to subject the surface to a hydrophilic treatment. Examples of the hydrophilic treatment include corona discharge treatment, plasma treatment, and arc discharge. There are treatments, flame treatments, etc., but from the viewpoint of the resulting hydrophilic effect and ease of imparting hydrophilicity, corona discharge treatment and plasma treatment are preferred.

コロナ放電処理とは、大気圧下、電極間に1kV以上の高電圧を印加し、放電することで行う処理のことであり、春日電機(株)や(株)トーヨー電機などで市販されている装置を用いて行うことが出来る。コロナ放電処理に用いる周波数は、20kHz以上100kHz以下の周波数であり、30kHz〜60kHzの周波数が好ましい。周波数が低下するとコロナ放電処理の均一性が劣化し、コロナ放電処理のムラが発生する。また、周波数が大きくなると、高出力のコロナ放電処理を行う場合には、特に問題ないが、低出力のコロナ放電処理を実施する場合には、安定した処理を行うことが難しくなり、結果として、処理ムラが発生する。   The corona discharge treatment is a treatment performed by applying a high voltage of 1 kV or higher between the electrodes at atmospheric pressure and discharging it, and is commercially available from Kasuga Electric Co., Ltd. and Toyo Electric Co., Ltd. It can be performed using an apparatus. The frequency used for the corona discharge treatment is a frequency of 20 kHz to 100 kHz, and a frequency of 30 kHz to 60 kHz is preferable. When the frequency is lowered, the uniformity of the corona discharge treatment is deteriorated, and unevenness of the corona discharge treatment occurs. In addition, when the frequency is increased, there is no particular problem when performing a high output corona discharge treatment, but when performing a low output corona discharge treatment, it becomes difficult to perform a stable treatment. Processing unevenness occurs.

プラズマ放電処理は、プラズマ放電処理装置等により、アルゴンまたは酸素雰囲気下でポリマー基材を高周波放電雰囲気化に晒すことにより行うことが出来る。大気圧プラズマ処理法としては、例えば、特開平11−181573号、特開2000−26632号、同2002−110397号等に記載の高周波パルス電圧を印加する大気圧プラズマ放電処理方法を用いることができる。   The plasma discharge treatment can be performed by exposing the polymer substrate to a high frequency discharge atmosphere in an argon or oxygen atmosphere with a plasma discharge treatment apparatus or the like. As an atmospheric pressure plasma treatment method, for example, an atmospheric pressure plasma discharge treatment method for applying a high-frequency pulse voltage described in JP-A Nos. 11-181573, 2000-26632, 2002-1109797, and the like can be used. .

本発明のカプセル内視鏡の適用方法の一例として、上述した内視鏡観察系で上部および下部消化器内の癌の早期発見のための内視鏡検査について説明する。まず、医師は、内視鏡観察系を用意し、検査を希望する被検者にカプセル内視鏡1の錠剤を飲むように8時間前に絶食するように前準備をさせる。そして、少量の水と共に口腔内に投与し、消化器内を速やかに移動するに従い、画像の無線送信が開始され、画像データのストレージを開始する。場合によっては液晶モニタ又は家庭用TVの画面上に表示される。   As an example of an application method of the capsule endoscope of the present invention, an endoscopy for early detection of cancer in the upper and lower digestive organs using the above-described endoscope observation system will be described. First, a doctor prepares an endoscope observation system, and prepares a subject who desires an examination to fast for 8 hours so as to drink a tablet of the capsule endoscope 1. Then, as it is administered into the oral cavity together with a small amount of water and moves quickly through the digestive organ, wireless transmission of images is started and storage of image data is started. In some cases, it is displayed on the screen of a liquid crystal monitor or home TV.

以下、実施例を挙げて本発明を具体的に説明するが、本発明はこれらに限定されるものではない。なお、実施例において「部」あるいは「%」の表示を用いるが、特に断りがない限り「質量部」あるいは「質量%」を表す。   EXAMPLES Hereinafter, the present invention will be specifically described with reference to examples, but the present invention is not limited thereto. In addition, although the display of "part" or "%" is used in an Example, unless otherwise indicated, "part by mass" or "mass%" is represented.

実施例1
《カプセル内視鏡の作製》
〔カプセル内視鏡101の作製〕
図1に記載の対物レンズ、照明光源部、固体撮像素子等が一体に組み込まれた構成からなり、保護部材Sをフェニルジイソシアナートで架橋し、かつ一部疎水化処理した耐水化処理ゼラチンを用い、厚さ200μmで成型して取り付けたカプセル内視鏡101を作製した。この一部疎水化したゼラチンで形成した保護部材表面の濡れ指数は、38mN/mであった。
Example 1
<< Preparation of capsule endoscope >>
[Preparation of capsule endoscope 101]
The objective lens, illumination light source unit, solid-state imaging device, etc. shown in FIG. 1 are integrally incorporated, and water-resistant gelatin obtained by crosslinking the protective member S with phenyl diisocyanate and partially hydrophobizing it is used. Used was a capsule endoscope 101 molded and attached with a thickness of 200 μm. The wetting index of the surface of the protective member made of this partially hydrophobized gelatin was 38 mN / m.

〔カプセル内視鏡102の作製〕
図1に記載の対物レンズ、照明光源部、固体撮像素子等が一体に組み込まれた構成からなり、保護部材Sをポリメタクリル酸メチル(三菱ガス化学社性モノマーを重合した樹脂、PMMAと略す)を用い、厚さ200μmで成型して取り付けたカプセル内視鏡102を作製した。このポリメタクリル酸メチルで形成した保護部材表面の濡れ指数は、32mN/mであった。
[Preparation of capsule endoscope 102]
The objective lens, the illumination light source unit, the solid-state imaging device, and the like shown in FIG. 1 are integrally incorporated, and the protective member S is polymethyl methacrylate (resin polymerized with a monomer manufactured by Mitsubishi Gas Chemical Company, abbreviated as PMMA). Was used to produce a capsule endoscope 102 molded and attached to a thickness of 200 μm. The wetting index of the surface of the protective member formed of this polymethyl methacrylate was 32 mN / m.

〔カプセル内視鏡103の作製〕
図1に記載の対物レンズ、照明光源部、固体撮像素子等が一体に組み込まれた構成からなり、保護部材Sをノルボルネン樹脂(日本ゼオン製樹脂ゼオノア1020R、COPと略す)を用い、厚さ200μmで成型して取り付けたカプセル内視鏡103を作製した。このノルボルネン樹脂で形成した保護部材表面の濡れ指数は、32mN/mであった。
[Preparation of capsule endoscope 103]
The objective lens, the illumination light source unit, the solid-state imaging device, and the like shown in FIG. A capsule endoscope 103 that was molded and attached with the above was manufactured. The wetting index of the surface of the protective member formed with this norbornene resin was 32 mN / m.

〔カプセル内視鏡104〜106の作製〕
上記カプセル内視鏡101〜103の作製において、保護部材Sの全面積の50%相当を、12kVの出力でコロナ放電処理装置(春日電機社製)を用いてコロナ放電処理を1秒間行って、表面の濡れ指数を54mN/mとした以外は同様にして、カプセル内視鏡104〜106を作製した。
[Preparation of capsule endoscopes 104 to 106]
In the production of the capsule endoscopes 101 to 103, a corona discharge treatment corresponding to 50% of the total area of the protective member S is performed for 1 second using a corona discharge treatment apparatus (manufactured by Kasuga Denki Co., Ltd.) at an output of 12 kV. Capsule endoscopes 104 to 106 were manufactured in the same manner except that the surface wetting index was set to 54 mN / m.

〔カプセル内視鏡107の作製〕
上記カプセル内視鏡104の作製において、保護部材Sの部材をフェニルジイソシアナートで架橋した耐水化処理ゼラチンを、ポリプロピレン樹脂(PPと略す)に変更した以外は同様にして、カプセル内視鏡107を作製した。
[Preparation of capsule endoscope 107]
In the manufacture of the capsule endoscope 104, the capsule endoscope 107 is similarly manufactured except that the water-resistant gelatin obtained by crosslinking the member of the protective member S with phenyl diisocyanate is changed to polypropylene resin (abbreviated as PP). Was made.

〔カプセル内視鏡108の作製〕
上記カプセル内視鏡104の作製において、保護部材Sの部材をフェニルジイソシアナートで架橋した耐水化処理ゼラチンを、ポリエチレン樹脂(PEと略す)に変更した以外は同様にして、カプセル内視鏡108を作製した。
[Preparation of capsule endoscope 108]
In the manufacture of the capsule endoscope 104, the capsule endoscope 108 is similarly manufactured except that the water-resistant gelatin obtained by crosslinking the member of the protective member S with phenyl diisocyanate is changed to polyethylene resin (abbreviated as PE). Was made.

〔カプセル内視鏡109〜113の作製〕
上記カプセル内視鏡104〜108の作製において、保護部材Sの全面積の50%相当を、コロナ放電処理に代えて、芝浦メカトロニクス社製のプラズマ処理装置(出力500W、発生源:2.45GHzマイクロ波、処理圧力:40Pa(0.3Torr))を用いて、表面の濡れ指数を54mN/mとなるようにプラズマ処理を施した以外は同様にして、カプセル内視鏡109〜113を作製した。
[Preparation of capsule endoscopes 109 to 113]
In the production of the capsule endoscopes 104 to 108, a plasma treatment apparatus (output: 500 W, generation source: 2.45 GHz micro) manufactured by Shibaura Mechatronics Co., Ltd. was used instead of corona discharge treatment for 50% of the total area of the protective member S. Capsule endoscopes 109 to 113 were manufactured in the same manner except that plasma treatment was performed using a wave and a treatment pressure of 40 Pa (0.3 Torr) so that the surface wetting index was 54 mN / m.

〔カプセル内視鏡114〜119の作製〕
上記カプセル内視鏡110(母材ポリマー:PMMA)の作製において、上記プラズマ処理を施した後、下記のE化処理の処理面積を、表1に記載のように変更した以外は同様にして、カプセル内視鏡114〜119を作製した。
[Preparation of capsule endoscopes 114 to 119]
In the production of the capsule endoscope 110 (matrix polymer: PMMA), after performing the plasma treatment, the treatment area of the following E treatment was changed in the same manner as described in Table 1, Capsule endoscopes 114-119 were produced.

E化処理:PMMA表面をpH12の水酸化ナトリウム液でアルカリ加水分解した後、エチレンオキサイドによるポリオキシエチレン化(繰り返し単位6)を行った。   E-treatment: The surface of PMMA was alkali-hydrolyzed with a sodium hydroxide solution having a pH of 12, and then polyoxyethylenated with ethylene oxide (repeating unit 6).

〔カプセル内視鏡120〜122の作製〕
上記カプセル内視鏡119(処理面積:100%)の作製において、E化処理に代えて、下記のT化処理、S化処理、P化処理にそれぞれ変更した以外は同様にして、カプセル内視鏡120〜122を作製した。
[Preparation of capsule endoscopes 120 to 122]
In the production of the capsule endoscope 119 (processing area: 100%), the capsule endoscope was changed in the same manner except that instead of the E conversion process, the following T conversion process, S conversion process, and P conversion process were performed. Mirrors 120-122 were made.

T化処理:PMMA表面をpH12の水酸化ナトリウム液でアルカリ加水分解した後、ヒドロキシエチルセルロースをメチルエチルケトン溶媒に溶解し、1.0μmの厚さで塗布し、乾燥させて、糖鎖構造化した。   T-treatment: After alkaline hydrolysis of the PMMA surface with a sodium hydroxide solution having a pH of 12, hydroxyethyl cellulose was dissolved in a methyl ethyl ketone solvent, applied to a thickness of 1.0 μm, and dried to form a sugar chain structure.

S化処理:PMMA表面をpH12の水酸化ナトリウム液でアルカリ加水分解した後、スルホン酸によるスルホン化処理を行った。   S conversion treatment: The PMMA surface was alkali-hydrolyzed with a sodium hydroxide solution having a pH of 12, followed by sulfonation treatment with sulfonic acid.

P化処理:PMMA表面をpH12の水酸化ナトリウム液でアルカリ加水分解した後、リン酸によるリン酸化処理を行った。   P-treatment: The surface of PMMA was alkali-hydrolyzed with a sodium hydroxide solution having a pH of 12, and then phosphorylated with phosphoric acid.

〔カプセル内視鏡123の作製〕
上記カプセル内視鏡107(母材ポリマー:PP)の作製において、コロナ放電処理を行った後、E化処理(前出、処理化面積:100%)を施した以外は同様にして、カプセル内視鏡123を作製した。
[Preparation of capsule endoscope 123]
In the production of the capsule endoscope 107 (matrix polymer: PP), after the corona discharge treatment, E treatment (previous treatment, treated area: 100%) was performed in the same manner. The endoscope 123 was produced.

《カプセル内視鏡の評価》
〔表面の濡れ指数測定〕
上記作製した各カプセル内視鏡の保護部材表面を、下記の方法に従って濡れ指数の測定を行った。
<< Evaluation of capsule endoscope >>
[Measurement of surface wetting index]
The surface of the protective member of each capsule endoscope produced as described above was measured for the wetting index according to the following method.

「ポリエチレンおよびポリプロピレンフィルムのぬれ試験方法」(JIS K 6768)に定められた方法に従って、市販されている濡れ性標準試薬31mN/m〜54mN/m(数値の大きいほど親水性が向上する)を綿棒に浸し、それを被験体の表面に塗布し、表面温度を37℃に保ち、0.5秒後の値を測定した。この時、撥水することなしに、良く濡れた試薬番号の最小値を濡れ指数とした。   In accordance with the method defined in “Wetting Test Method for Polyethylene and Polypropylene Film” (JIS K 6768), a commercially available wettability standard reagent 31 mN / m to 54 mN / m (the higher the value, the higher the hydrophilicity) is swab It was dipped in, applied to the surface of the subject, the surface temperature was kept at 37 ° C., and the value after 0.5 seconds was measured. At this time, the wetness index was defined as the minimum value of the well-wet reagent number without water repellency.

〔耐久性の評価〕
上記作製した各カプセル内視鏡を、事前に採取して冷凍保存しておいた牛の胃液を解凍し、この胃液に1時間浸漬した後、撮影画像の送受信を行い、異常がないかどうかを評価した。全く異常なく送信できた場合を○、送信不良が発生した場合を×として判定した。
[Evaluation of durability]
Each capsule endoscope produced above was thawed from the bovine gastric juice that had been collected in advance and stored frozen, soaked in this gastric juice for 1 hour, and then sent and received to check whether there was any abnormality. evaluated. A case where transmission was possible without any abnormality was judged as ◯, and a case where transmission failure occurred was judged as X.

〔撮影画像の鮮明性評価〕
上記作製した各カプセル内視鏡を、人体の胃部から小腸までの模擬体内を移動させ、移動時に撮影画像を送信し、受診した撮影画像の鮮明度を目視観察し、下記の基準に従って撮影画像の鮮明性の評価を行った。
[Evaluation of sharpness of photographed image]
Each capsule endoscope produced above is moved in the simulated body from the stomach part of the human body to the small intestine, and a captured image is transmitted at the time of movement, and the sharpness of the taken captured image is visually observed, and the captured image is observed according to the following criteria: The clarity of the images was evaluated.

5:送信された撮影画像は、保護部材への付着物もなく、極めて鮮明で良好な画像である
4:送信された撮影画像は、保護部材への異物付着もなく、鮮明な画像である
3:送信された撮影画像には、一部で保護部材への付着物により、僅かに鮮明度は低下は認められるが、実用上は十分に耐えうる画質である
2:送信された撮影画像には、保護部材への異物付着による鮮明度の低下が認められ、実用上許容される画質水準を下回っている
1:送信された撮影画像には、保護部材へ多量の異物付着が認められ、大幅に鮮明度の低下が認められ、実用に耐えない画質である
以上により得られた結果を、表1に示す。
5: The transmitted photographed image is a very clear and good image with no adhering matter to the protective member. 4: The transmitted photographed image is a clear image with no foreign matter adhering to the protective member. : Slightly lower sharpness is observed in the transmitted photographed image due to a part adhering to the protective member, but the image quality can withstand practically. 2: In the transmitted photographed image Deterioration of sharpness due to foreign matter adhering to the protective member is recognized and is lower than a practically acceptable image quality level. 1: A large amount of foreign matter adhering to the protective member is recognized in the transmitted photographed image. Table 1 shows the results obtained by the above-mentioned results that the image quality is unacceptable for practical use.

表1に記載の結果より明らかなように、濡れ指数が40mN/m以上の表面部を有する本発明のカプセル内視鏡は、比較例に対し、強酸環境下で長時間にわたり保存された状態での耐久性に優れ、かつ撮影部位の保護部材に対する体腔内物質の付着耐性に優れ、極めて鮮明な画像を送信することが分かる。   As is apparent from the results shown in Table 1, the capsule endoscope of the present invention having a surface portion with a wetting index of 40 mN / m or more is in a state of being stored for a long time in a strong acid environment as compared with the comparative example. It can be seen that it has excellent durability and excellent adhesion resistance of the substance in the body cavity to the protective member at the imaging site, and transmits an extremely clear image.

実施例2
観察光学系及び照明光学系の構成を、図2に示す様に光源部カバー(ノルボルネン樹脂製)及び対物レンズ(ノルボルネン樹脂製)を最表面に配置し、光源部カバー及び対物レンズ表面を実施例1のカプセル内視鏡104〜123の作製と同様の表面処理を行った以外は同様にして、カプセル内視鏡204〜223を作製し、実施例1に記載の方法と同様に耐久性及び撮影画像の鮮明性の評価を行った結果、実施例1と同様の優れた結果を得ることができた。
Example 2
As shown in FIG. 2, the configuration of the observation optical system and the illumination optical system is such that the light source cover (made of norbornene resin) and the objective lens (made of norbornene resin) are arranged on the outermost surface, and the light source cover and the objective lens surface are examples. The capsule endoscopes 204 to 223 are manufactured in the same manner except that the same surface treatment as that for the manufacture of the capsule endoscopes 104 to 123 is performed, and the durability and photographing are performed in the same manner as the method described in the first embodiment. As a result of evaluating the sharpness of the image, the same excellent results as in Example 1 could be obtained.

Claims (7)

濡れ指数が40mN/m以上の表面部Aを有することを特徴とするカプセル内視鏡。 A capsule endoscope having a surface portion A having a wetting index of 40 mN / m or more. 前記表面部Aが、レンズ及び照明体を収納した撮影部の保護部材であることを特徴とする請求の範囲第1項に記載のカプセル内視鏡。 The capsule endoscope according to claim 1, wherein the surface portion A is a protective member of an imaging unit that houses a lens and an illuminating body. 前記表面部Aが、レンズ表面または照明体表面であることを特徴とする請求の範囲第1項に記載のカプセル内視鏡。 The capsule endoscope according to claim 1, wherein the surface portion A is a lens surface or an illuminator surface. 前記表面部Aが、コロナ放電処理またはプラズマ放電処理されていることを特徴とする請求の範囲第1項〜第3項のいずれか1項に記載のカプセル内視鏡。 The capsule endoscope according to any one of claims 1 to 3, wherein the surface portion A is subjected to corona discharge treatment or plasma discharge treatment. 前記表面部Aを構成する素材が、ノニオン性基またはアニオン性基を有するポリマーであることを特徴とする請求の範囲第1項〜第4項のいずれか1項に記載のカプセル内視鏡。 The capsule endoscope according to any one of claims 1 to 4, wherein the material constituting the surface portion A is a polymer having a nonionic group or an anionic group. 前記ノニオン性基が、単独の水酸基、複数の水酸基を有する糖鎖構造及びアルキレンオキサイド基から選ばれる少なくとも1つであることを特徴とする請求の範囲第5項に記載のカプセル内視鏡。 The capsule endoscope according to claim 5, wherein the nonionic group is at least one selected from a single hydroxyl group, a sugar chain structure having a plurality of hydroxyl groups, and an alkylene oxide group. 前記アニオン性基が、スルホン酸基または燐酸基であることを特徴とする請求の範囲第5項に記載のカプセル内視鏡。 The capsule endoscope according to claim 5, wherein the anionic group is a sulfonic acid group or a phosphoric acid group.
JP2007518896A 2005-06-03 2006-05-16 Capsule endoscope Expired - Fee Related JP5003486B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007518896A JP5003486B2 (en) 2005-06-03 2006-05-16 Capsule endoscope

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2005163689 2005-06-03
JP2005163689 2005-06-03
PCT/JP2006/309686 WO2006129472A1 (en) 2005-06-03 2006-05-16 Capsule endoscope
JP2007518896A JP5003486B2 (en) 2005-06-03 2006-05-16 Capsule endoscope

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011178790A Division JP5299483B2 (en) 2005-06-03 2011-08-18 Tablet capsule endoscope

Publications (2)

Publication Number Publication Date
JPWO2006129472A1 true JPWO2006129472A1 (en) 2008-12-25
JP5003486B2 JP5003486B2 (en) 2012-08-15

Family

ID=37481403

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007518896A Expired - Fee Related JP5003486B2 (en) 2005-06-03 2006-05-16 Capsule endoscope
JP2011178790A Expired - Fee Related JP5299483B2 (en) 2005-06-03 2011-08-18 Tablet capsule endoscope

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011178790A Expired - Fee Related JP5299483B2 (en) 2005-06-03 2011-08-18 Tablet capsule endoscope

Country Status (3)

Country Link
EP (1) EP1886618A4 (en)
JP (2) JP5003486B2 (en)
WO (1) WO2006129472A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2474309B (en) 2009-10-12 2011-09-07 Endoguard Ltd Flow guide for an endoscope
WO2015159770A1 (en) * 2014-04-14 2015-10-22 オリンパス株式会社 Capsule endoscope
CN104905757B (en) * 2015-06-30 2016-08-24 中国人民解放军成都军区总医院 There is the capsule endoscope of ultrasonic sensing
US11246480B2 (en) 2015-09-07 2022-02-15 Plasmatica Ltd. Preventing fog on a medical device viewport
US11896203B2 (en) 2015-09-07 2024-02-13 Plasmatica Ltd. Methods and systems for providing plasma treatments to optical surfaces
KR20230098716A (en) 2015-09-07 2023-07-04 플라즈마티카 리미티드 Preventing fog on a medical device viewport
US11896204B2 (en) 2015-09-07 2024-02-13 Plasmatica Ltd. Methods and systems for providing plasma treatments to optical surfaces
CN109662693A (en) * 2018-12-29 2019-04-23 深圳普门科技股份有限公司 A kind of miniature detection capsule of Hp based on gas detection
CN115364356B (en) * 2022-09-23 2023-08-04 王伟强 Clinical injection type medicine feeding device of using of gynaecology and obstetrics

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3631265B2 (en) 1994-04-27 2005-03-23 オリンパス株式会社 In-vivo observation device
US5932299A (en) * 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
JP3510786B2 (en) 1997-04-16 2004-03-29 積水化学工業株式会社 Thin film formation method using discharge plasma
JP2000026632A (en) 1998-07-13 2000-01-25 Sekisui Chem Co Ltd Thin film formation on film substrate using normal pressure plasma
JP4472069B2 (en) * 1999-11-10 2010-06-02 オリンパス株式会社 Medical capsule endoscope
JP4272783B2 (en) 1999-12-21 2009-06-03 Hoya株式会社 Objective optical system and endoscope objective optical system
JP2002110397A (en) 2000-09-27 2002-04-12 Sekisui Chem Co Ltd Generating method of normal pressure pulse plasma
US7008979B2 (en) * 2002-04-30 2006-03-07 Hydromer, Inc. Coating composition for multiple hydrophilic applications
US7001329B2 (en) * 2002-07-23 2006-02-21 Pentax Corporation Capsule endoscope guidance system, capsule endoscope holder, and capsule endoscope
JP2004121843A (en) * 2002-09-30 2004-04-22 Given Imaging Ltd System including optical head assembly, and dome, and in vivo imaging device
JP2005192820A (en) * 2004-01-07 2005-07-21 Olympus Corp Capsule type medical device

Also Published As

Publication number Publication date
EP1886618A1 (en) 2008-02-13
JP5003486B2 (en) 2012-08-15
WO2006129472A1 (en) 2006-12-07
EP1886618A4 (en) 2012-05-02
JP2012005852A (en) 2012-01-12
JP5299483B2 (en) 2013-09-25

Similar Documents

Publication Publication Date Title
JP5299483B2 (en) Tablet capsule endoscope
US9521946B2 (en) Transparent endoscope head defining a focal length
US20220409012A1 (en) Imaging Apparatus and Method Which Utilizes Multidirectional Field of View Endoscopy
US20050288582A1 (en) Micro medical-ultrasonic endoscopic OCT probe
US10517468B2 (en) Capsule medical device having positioning member with abutment surfaces
JP5242101B2 (en) Capsule endoscope
JP2004344655A (en) Endoscopic device
JP2001137182A (en) Capsule endoscope for medical use
CN1617687A (en) Apparatus and method for spectroscopic examination of the colon
US20100076261A1 (en) Examination device
WO2009014895A1 (en) Endoscope assembly and method of viewing an area inside a cavity
JPWO2008062594A1 (en) Capsule endoscope
WO2006045011A2 (en) Endocapsule
JPWO2006132066A1 (en) Medical capsule endoscope
CN202654130U (en) Capsule endoscopy system with ultrasound system
JP2006334141A (en) Capsule endoscope
JP2004522467A (en) Ingestible capsule for transmitting fluorescent images
JP2007075248A (en) Capsule endoscope
KR101630849B1 (en) endoscope
JP2006239439A (en) Capsule type endoscope
KR20220021240A (en) Digestive system diagnostic wire/wireless endoscope
CN107708573A (en) Ultrasonic endoscope
CN215874574U (en) Capsule endoscope with optical film
Filip Self–stabilizing capsule endoscope for early detection and biopsy of colonic polyps
JP3884454B2 (en) Capsule medical device

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090313

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110621

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20110818

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120221

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120329

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120424

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120507

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150601

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees